據報鬆下擬於美國設新廠房 爲特斯拉(TSLA.US)供應電池
據《日經亞洲》報道,鬆下(Panasonic)(PCRFF.US)正計劃於美國建設新廠房,爲特斯拉(TSLA.US)供應最新款的4680電池,用於特斯拉Semi及Cybertruck等新車型,預期最快可於2024年營運。
報道指,鬆下計劃獨立營運新工廠,但最終是否建廠,將要取決於鬆下日本和歌山縣工廠生產新型鋰離子電池的盈利能力,最終選址則將根據地方政府的補貼和其他支持措施而定,候選地點包括接近特斯拉德州新工廠的俄克拉何馬州。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.